FIELD: medicine; pharmaceutics.
SUBSTANCE: proposed invention relates to a method for stimulating the immune response of a living organism. Method for stimulating the immune response of a living body, wherein baricitinib is used in dose of 1 to 1000 pg/kg of body weight.
EFFECT: method described above effectively stimulates the immune response of a living organism.
1 cl, 6 dwg, 14 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION REGULATING IMMUNE RESPONSE OF LIVING BODY | 2021 |
|
RU2826103C2 |
| {3-[4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)PYRAZOLE-1-YL]-1-ETHYLSULFONYL-AZETIDINE-3-YL}-ACETONITRILE DICHLOROACETATE AS JANUS KINASE INHIBITOR | 2015 |
|
RU2603959C1 |
| AMINOPYRAZOLES AS SELECTIVE JANUS KINASE INHIBITORS | 2017 |
|
RU2757218C2 |
| PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES | 2021 |
|
RU2819004C1 |
| 2-(3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-1-(ETHYLSULFONYL)AZETIDIN-3-YL)ACETONITRILE HEMINAPHTHYLDISULFONATE AS JANUS KINASE INHIBITOR | 2016 |
|
RU2644155C1 |
| NEW DERIVATIVES OF AMINOIMIDAZOPYRIMIDINE AS JANUS KINASE INHIBITORS AND PHARMACEUTICAL APPLICATION THEREOF | 2019 |
|
RU2772463C1 |
| THERAPEUTIC COMPOUNDS AND COMPOSITIONS AND METHODS OF USING THEM | 2018 |
|
RU2769696C2 |
| PHARMACEUTICAL COMPOSITION WITH CYTOKINE AND IMMUNOMODULATING EFFECTS | 2002 |
|
RU2222345C2 |
| NEW SYNTHETIC TLR9 AGONISTS | 2008 |
|
RU2468819C2 |
| COMPOSITION BASED UPON THE PROTEINS OF ENAMEL MATRIX FOR MODULATING IMMUNE RESPONSE | 2002 |
|
RU2295972C2 |
